Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
REPL - OTHER CURRENT ASSETS
Other Current Assets REPL - Replimune Group, Inc.
8.08 M
LAST VALUE
57.24%
2 YEAR CAGR
16.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR